SCHEMBL19082131

SCHEMBL19082131

c1ccc2cc(-c3c4ccccc4c(-c4ccc5c(c4)sc4cc6sc7ccc8ccccc8c7c6cc45)c4ccccc34)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 2/20 0.35
NQO1 P15559 1/20 0.35
CYP1A1 P04798 3/20 0.34
CYP1B1 Q16678 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 3/20 0.33
RAB9A P51151 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
PDE9A O76083 1/20 0.32
ALOX5 P09917 2/20 0.31
GSTP1 P09211 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
CYP1A2 P05177 3/20 0.31
S1PR4 O95977 1/20 0.30
S1PR5 Q9H228 1/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082286 0.96 ESR1 (0.35) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL19082171 0.95 HSD17B1 (0.35) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL19082343 0.94 F9 (0.36) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL19082201 0.94 F9 (0.39) NQO2NQO1CYP1A1CYP1B1ESR1
SCHEMBL19082123 0.93 NQO2 (0.36) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL19082290 0.92 ESR1 (0.36) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL17944156 0.92 NQO2 (0.38) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL19082145 0.91 F9 (0.35) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL13303977 0.91 NQO2 (0.38) NQO2NQO1CYP1A1CYP1B1SMN1; SMN2
SCHEMBL19082379 0.91 PIM1 (0.32) NQO2NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO2 2592/4885NQO1 576/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.